nabumetone has been researched along with Jejunal Diseases in 1 studies
Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.
Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Somasundaram, S | 1 |
| Simpson, R | 1 |
| Rafi, S | 1 |
| Shergill, JK | 1 |
| Bjarnason, I | 1 |
| Wrigglesworth, J | 1 |
1 other study available for nabumetone and Jejunal Diseases
| Article | Year |
|---|---|
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Cell Membrane Permeability; Electron Sp | 2002 |